JACOBIO-B (01167) receives the down payment under the capital increase agreement and equity transfer agreement.
Jiakesi-B (01167) announced that it has entered into a capital increase agreement and equity transfer agreement with Beijing Jiakesi, Jiakerikang, Haicong Capital, and an industrial cooperation partner. The company's board of directors happily announced that its indirect non-wholly-owned subsidiary, Beijing Jiakesi, has received the first payment of RMB 125 million from Haicong Capital for the capital increase agreement and equity transfer agreement. The receipt of this first payment further replenishes the group's cash reserves and will provide support for the group's ongoing research and development of innovative cancer therapy pipelines.
JACOBIO-B (01167) issued an announcement regarding the capital increase agreement and equity transfer agreement signed with Beijing Jiakebi, Jiake Ruikang, Haicong Capital, and an industrial cooperation partner. The company's board of directors happily announced that its subsidiary Beijing Jiakebi (an indirectly owned non-wholly owned subsidiary) has received the first payment of RMB 125 million from Haicong Capital for the signed capital increase agreement and equity transfer agreement. The receipt of this first payment has further increased the group's cash reserves and will provide support for the advancement of the group's future innovative pipeline research in cancer therapy.
Related Articles
HK Stock Market Move | Giant Biogene (02367) rose more than 6% in the afternoon, and plans to repurchase up to 104 million shares.
JINHUI HOLDINGS (00137) subsidiary plans to sell a super large Handy bulk carrier for USD 14.4 million
GIANT BIOGENE (02367) plans to repurchase shares based on the authorization to repurchase shares.
HK Stock Market Move | Giant Biogene (02367) rose more than 6% in the afternoon, and plans to repurchase up to 104 million shares.
JINHUI HOLDINGS (00137) subsidiary plans to sell a super large Handy bulk carrier for USD 14.4 million
GIANT BIOGENE (02367) plans to repurchase shares based on the authorization to repurchase shares.
RECOMMEND
